Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Fluorouracil 1-Hour Infusion + Leucovorin + IFN-alpha-2a in Advanced Colorectal Cancer
NCT00001428Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in colorectal cancer (CRC), sponsored by National Cancer Institute. Primary endpoint: Objective Response Rate. Started Feb 1995; status: completed.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00001428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001428.